Global Digital Polymerase Chain Reaction (PCR) and Real-time PCR (qPCR) Market Growth, Share, Size, Trends and Forecast (2025 - 2031)

By Technology;

Quantitative PCR (qPCR) and Digital PCR (dPCR)

By Product and Service;

qPCR Products and Services - (qPCR Reagents & Consumables, qPCR Instruments, and qPCR Software & Services), dPCR Products and Services - (dPCR Instruments, dPCR Reagents & Consumables, and dPCR Software & Services)

By Application;

qPCR Applications - (Clinical Applications[Pathogen Testing, Oncology Testing, Blood Screening, and Others], Research Applications, and Forensic Applications), dPCR Applications - (Clinical Applications [Pathogen Testing, Oncology Testing, Blood Screening, and Others], Research Applications, and Forensic Applications)

By End User;

Quantitative PCR (qPCR) End Users - (Hospitals & Diagnostic Centers, Research Laboratories & Academic Institutes, Pharmaceutical & Biotechnology Companies, Clinical Research Organizations, and Forensic Laboratories), Digital PCR (dPCR) End Users - (Research Laboratories & Academic Institutes, Hospitals & Diagnostic Centers, Pharmaceutical & Biotechnology Companies, Clinical Research Organizations, and Forensic Laboratories)

By Geography;

North America, Europe, Asia Pacific, Middle East & Africa, and Latin America - Report Timeline (2021 - 2031)
Report ID: Rn329373342 Published Date: May, 2025 Updated Date: June, 2025

Introduction

Global Digital Polymerase Chain Reaction (PCR) and Real-time PCR (qPCR) Market (USD Million), 2021 - 2031

Digital Polymerase Chain Reaction (PCR) and Real-time PCR (qPCR) Market was valued at USD 1,535.34 million in the year 2024. The size of this market is expected to increase to USD 2,433.34 million by the year 2031, while growing at a Compounded Annual Growth Rate (CAGR) of 6.8%.


Global Digital Polymerase Chain Reaction (PCR) and Real-time PCR (qPCR) Market Growth, Share, Size, Trends and Forecast

*Market size in USD million

CAGR 6.8 %


Study Period2025 - 2031
Base Year2024
CAGR (%)6.8 %
Market Size (2024)USD 1,535.34 Million
Market Size (2031)USD 2,433.34 Million
Market ConcentrationMedium
Report Pages374
1,535.34
2024
2,433.34
2031

Major Players

  • F. Hoffman-La Roche Ltd.
  • Thermo Fisher Scientific, Inc.
  • Bio-Rad Laboratories, Inc.
  • Qiagen N.V.
  • Takara Bio, Inc.
  • Agilent Technologies, Inc.
  • Biomrieux S.A.
  • Fluidigm Corporation
  • Danaher Corporation
  • Abbott Laboratories

Market Concentration

Consolidated - Market dominated by 1 - 5 major players

Global Digital Polymerase Chain Reaction (PCR) and Real-time PCR (qPCR) Market

Fragmented - Highly competitive market without dominant players


The Digital Polymerase Chain Reaction (PCR) and Real-time PCR (qPCR) Market is witnessing significant growth, fueled by the rising demand for precision diagnostics. Approximately 65% of molecular diagnostic tests now utilize PCR technologies, reflecting their critical role in accurate disease detection and genetic analysis. This surge in demand is primarily driven by the need for highly sensitive and quantitative testing, making these methods essential for identifying infectious diseases, cancers, and genetic disorders.

Breakthroughs in PCR Technology
Recent advancements in PCR technologies have considerably enhanced testing speed, precision, and reliability. Digital PCR, recognized for its exceptional sensitivity and accuracy, has emerged as a key growth area, contributing nearly 30% to the overall PCR market. These innovations aim to reduce error rates, improve quantification accuracy, and enable the detection of ultra-low target concentrations, supporting applications like liquid biopsy and early-stage cancer detection.

Diverse Applications in Research and Clinical Practice
PCR technologies have found extensive use across research and clinical environments, supporting a wide range of diagnostic and analytical applications. Nearly 70% of research facilities and diagnostic labs rely on qPCR for gene expression analysis, pathogen detection, and DNA quantification, highlighting the critical role of these methods in advancing biomedical research and personalized medicine.

Focus on Cost-Effective and Automated Solutions
The industry is increasingly prioritizing the development of cost-effective and automated PCR systems to streamline diagnostic workflows. Automated qPCR platforms now make up over 45% of the market, offering improved laboratory efficiency, reduced human error, and faster turnaround times, addressing the demand for rapid and reliable diagnostic solutions.

  1. Introduction
    1. Research Objectives and Assumptions
    2. Research Methodology
    3. Abbreviations
  2. Market Definition & Study Scope
  3. Executive Summary
    1. Market Snapshot, By Technology
    2. Market Snapshot, By Product and Service
    3. Market Snapshot, By Application
    4. Market Snapshot, By End User
    5. Market Snapshot, By Region
  4. Global Digital Polymerase Chain Reaction (PCR) and Real-time PCR (qPCR) Market Dynamics
    1. Drivers, Restraints and Opportunities
      1. Drivers
        1. Rising Demand for Molecular Diagnostics
        2. Increasing Prevalence of Infectious Diseases
        3. Increased use in personalized medicine research
      2. Restraints
        1. High cost of dPCR instruments and reagents
        2. Complex data interpretation and analysis
        3. Limited Accessibility in Developing Regions
      3. Opportunities
        1. Adoption in oncology and liquid biopsy testing
        2. Use in environmental and food safety monitoring
        3. Automation improving laboratory throughput
    2. PEST Analysis
      1. Political Analysis
      2. Economic Analysis
      3. Social Analysis
      4. Technological Analysis
    3. Porter's Analysis
      1. Bargaining Power of Suppliers
      2. Bargaining Power of Buyers
      3. Threat of Substitutes
      4. Threat of New Entrants
      5. Competitive Rivalry
  5. Market Segmentation
    1. Global Digital Polymerase Chain Reaction (PCR) and Real-time PCR (qPCR) Market, By Technology, 2021 - 2031 (USD Million)
      1. Quantitative PCR
      2. Digital PCR
    2. Global Digital Polymerase Chain Reaction (PCR) and Real-time PCR (qPCR) Market, By Product and Service, 2021 - 2031 (USD Million)
      1. qPCR Products and Services
        1. qPCR Reagents & Consumables
        2. qPCR Instruments
        3. qPCR Software and Services
      2. dPCR Products and Services
        1. dPCR Instruments
        2. dPCR Reagents & Consumables
        3. dPCR Software & Services
    3. Global Digital Polymerase Chain Reaction (PCR) and Real-time PCR (qPCR) Market, By Application, 2021 - 2031 (USD Million)
      1. qPCR Applications
        1. Clinical Applications
          1. Pathogen Testing
          2. Oncology Testing
          3. Blood Screening
          4. Others
        2. Research Applications
        3. Forensic Applications
      2. dPCR Applications
        1. Clinical Applications
          1. Pathogen Testing
          2. Oncology Testing
          3. Blood Screening
          4. Others
        2. Research Applications
        3. Forensic Applications
    4. Global Digital Polymerase Chain Reaction (PCR) and Real-time PCR (qPCR) Market, By End User, 2021 - 2031 (USD Million)
      1. Quantitative PCR (qPCR) End Users
        1. Hospitals & Diagnostic Centers
        2. Research Laboratories & Academic Institutes
        3. Pharmaceutical & Biotechnology Companies
        4. Clinical Research Organizations
        5. Forensic Laboratories
      2. Digital PCR (dPCR) End Users
        1. Research Laboratories & Academic Institutes
        2. Hospitals & Diagnostic Centers
        3. Pharmaceutical & Biotechnology Companies
        4. Clinical Research Organizations
        5. Forensic Laboratories
    5. Global Digital Polymerase Chain Reaction (PCR) and Real-time PCR (qPCR) Market, By Geography, 2021 - 2031 (USD Million)
      1. North America
        1. United States
        2. Canada
      2. Europe
        1. Germany
        2. United Kingdom
        3. France
        4. Italy
        5. Spain
        6. Nordic
        7. Benelux
        8. Rest of Europe
      3. Asia Pacific
        1. Japan
        2. China
        3. India
        4. Australia & New Zealand
        5. South Korea
        6. ASEAN (Association of South East Asian Countries)
        7. Rest of Asia Pacific
      4. Middle East & Africa
        1. GCC
        2. Israel
        3. South Africa
        4. Rest of Middle East & Africa
      5. Latin America
        1. Brazil
        2. Mexico
        3. Argentina
        4. Rest of Latin America
  6. Competitive Landscape
    1. Company Profiles
      1. F. Hoffman-La Roche Ltd.
      2. Thermo Fisher Scientific, Inc.
      3. Bio-Rad Laboratories, Inc.
      4. Qiagen N.V.
      5. Takara Bio, Inc.
      6. Agilent Technologies, Inc.
      7. Biomrieux S.A.
      8. Fluidigm Corporation
      9. Danaher Corporation
      10. Abbott Laboratories
  7. Analyst Views
  8. Future Outlook of the Market